F
Florian Ringel
Researcher at University of Mainz
Publications - 133
Citations - 3484
Florian Ringel is an academic researcher from University of Mainz. The author has contributed to research in topics: Subarachnoid hemorrhage & Glioma. The author has an hindex of 26, co-authored 133 publications receiving 2627 citations. Previous affiliations of Florian Ringel include Technische Universität München.
Papers
More filters
Journal ArticleDOI
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial
Ulrich Herrlinger,Theophilos Tzaridis,Frederic Mack,Joachim P. Steinbach,Uwe Schlegel,Michael Sabel,Peter Hau,Rolf-Dieter Kortmann,Dietmar Krex,Oliver Grauer,Roland Goldbrunner,Oliver Schnell,Oliver Schnell,Oliver Bähr,Martin Uhl,Clemens Seidel,Ghazaleh Tabatabai,Thomas Kowalski,Florian Ringel,Florian Ringel,Friederike Schmidt-Graf,Bogdana Suchorska,Stefanie Brehmer,Astrid Weyerbrock,Miriam Renovanz,Lars Bullinger,Norbert Galldiks,Peter Vajkoczy,Martin Misch,Hartmut Vatter,Moritz Stuplich,Niklas Schäfer,Sied Kebir,Johannes Weller,Christina Schaub,Walter Stummer,Jörg-Christian Tonn,Matthias Simon,Vera C. Keil,Michael Nelles,Horst Urbach,Horst Urbach,Martin Coenen,Wolfgang Wick,Michael Weller,Rolf Fimmers,Matthias Schmid,Elke Hattingen,Torsten Pietsch,Christoph Coch,Martin Glas,Martin Glas +51 more
TL;DR: The results suggest that lomustine-temozolomide chemotherapy might improve survival compared with temozolmide standard therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter.
Journal ArticleDOI
Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.
Peter Vajkoczy,Bernhard Meyer,Stefan Weidauer,Andreas Raabe,Claudius Thomé,Florian Ringel,Volker Breu,Peter Schmiedek +7 more
TL;DR: This study indicates that clazosentan reduces the frequency and severity of cerebral vasospasm following severe aneurysmal SAH with the incidence of adverse events comparable to that of placebo.
Journal ArticleDOI
Utility of presurgical navigated transcranial magnetic brain stimulation for the resection of tumors in eloquent motor areas
Sandro M. Krieg,Ehab Shiban,Niels Buchmann,Jens Gempt,Annette Foerschler,Bernhard Meyer,Florian Ringel +6 more
TL;DR: Navigated transcranial magnetic stimulation correlates well with DCS as a gold standard despite factors that are supposed to contribute to the inaccuracy of nTMS.
Journal ArticleDOI
Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection.
Florian Ringel,Haiko Pape,Michael Sabel,Dietmar Krex,Hans Christoph Bock,Martin Misch,Astrid Weyerbrock,Thomas Westermaier,Christian Senft,Philippe Schucht,Bernhard Meyer,Matthias Simon,Marion Rapp,Veit Rohde,Marcia Machein,Ralf-Ingo Ernestus,Kea Franz,Jürgen Beck,Peter Vajkoczy,Mehrdad Salehi,Mario N. Carvi y Nievas,Hans-Georg Höllerhage,Thomas Schneider,Humberto Tapia-Perez,Anke Höllig,Hans Clusmann,Wiebke Aumann,Thomas Kretschmer,Marcel Seiz-Rosenhagen,Claudius Thomé,Rüdiger Buchalla,Christian Groß,Florian Stockhammer,Ivan Radovanovic,Karl Lothard Schaller,Petra Wolf +35 more
TL;DR: The view that surgical resections of recurrent glioblastomas may help to prolong patient survival at an acceptable complication rate is supported.
Journal ArticleDOI
Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity
Michael Rasper,Andrea Schäfer,Guido Piontek,Julian Teufel,Gero Brockhoff,Florian Ringel,Stefan Heindl,Claus Zimmer,Jürgen Schlegel +8 more
TL;DR: This work suggests aldehyde dehydrogenase 1 (ALDH1) as a novel stem cell marker in human GBM and shows that high protein levels of ALDH1 facilitate neurosphere formation in established GBM cell lines.